These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 14247356)
1. THE PROPERTIES OF A NEW TYPE 3 ATTENUATED POLIOVIRUS. I. DERIVATION OF NEW TYPE 3 ATTENUATED POLIOVIRUSES AND THEIR LABORATORY CHARACTERISTICS. VONKA V; JANDA Z; SIMON J Arch Gesamte Virusforsch; 1964 Jun; 14():599-610. PubMed ID: 14247356 [No Abstract] [Full Text] [Related]
2. INTRATYPIC SERODIFFERENTIATION TESTS ON POLIO TYPE 1 VIRUS STRAINS ISOLATED BEFORE AND AFTER VACCINATION WITH ATTENUATED SABIN TYPE 1 POLIO VACCINE. HAHNEMANN F; SIBONI K; GODTFREDSEN A Acta Pathol Microbiol Scand; 1964; 61():437-45. PubMed ID: 14164891 [No Abstract] [Full Text] [Related]
3. MARKER TEST OF POLIOVIRUS IN RELATION TO MASS VACCINATION WITH LIVE ORAL VACCINES. TOYOSHIMA K; MITSUDA B; TADOKORO J; YAMADA T; KUNITA N Biken J; 1963 Jul; 6():57-72. PubMed ID: 14147706 [No Abstract] [Full Text] [Related]
4. CHARACTERISTICS OF SABIN TYPE 1 POLIOVIRUS AFTER GASTROINTESTINAL PASSAGE IN NEWBORN INFANTS. II. ANTIGENICITY AND ELUTION FROM AL(OH)3 GEL. WOODS WA; ROBBINS FC; WEISS RA; CASHEL J; KIRSCHSTEIN RL Am J Hyg; 1964 Mar; 79():236-44. PubMed ID: 14131876 [No Abstract] [Full Text] [Related]
5. [EVALUATION OF NEURAL LESIONS IN MONKEYS INOCULATED WITH SABIN POLIOVIRUS VACCINE]. LUSSIER G; PAVILANIS V; DIFRANCO E Rev Can Biol; 1964 Sep; 23():323-32. PubMed ID: 14237165 [No Abstract] [Full Text] [Related]
6. [STUDIES ON TESTING THE SAFETY OF INACTIVATED POLIOMYELITIS VACCINES. II. SV 40 IN INACTIVATED POLIOMYELITIS VACCINES]. GUENTHER O; HOEVEL H; VON METTENHEIM Zentralbl Bakteriol Orig; 1963 Dec; 190():445-65. PubMed ID: 14166424 [No Abstract] [Full Text] [Related]
7. GENETIC MARKERS OF POLIOVIRUS STRAINS ISOLATED FROM PARALYTIC PATIENTS PRIOR TO AND AFTER SABIN VACCINATION PROGRAMS. I. STUDIES ON TYPE 1 STRAINS. FURESZ J; ARMSTRONG RE; YAROSH W; NAGLER FP Am J Hyg; 1964 Jul; 80():45-54. PubMed ID: 14192769 [No Abstract] [Full Text] [Related]
8. THE USE OF A MODIFIED WECKER TECHNIQUE FOR SERODIFFERENTIATION OF TYPE 1 POLIOVIRUSES RELATED AND UNRELATED TO SABIN'S VACCINE STRAIN. II. ANTIGENIC SEGREGATION OF ISOLATES FROM SPECIMENS COLLECTED IN FIELD STUDIES. NAKANO JH; GELFAND HM; COLE JT Am J Hyg; 1963 Sep; 78():214-26. PubMed ID: 14063724 [No Abstract] [Full Text] [Related]
9. PROPERTIES OF A NEW ATTENUATED TYPE 3 POLIOVIRUS. II. NEUROVIRULENCE TESTS ON MONKEYS. SIMON J Arch Gesamte Virusforsch; 1965; 15():220-33. PubMed ID: 14269256 [No Abstract] [Full Text] [Related]
10. GENETIC MARKERS OF POLIOVIRUS STRAINS ISOLATED FROM PARALYTIC PATIENTS PRIOR TO AND AFTER SABIN VACCINATION PROGRAMS. II. STUDIES ON TYPE 3 STRAINS. FURESZ J; ARMSTRONG RE; MOREAU P; NAGLER FP Am J Hyg; 1964 Jul; 80():55-61. PubMed ID: 14192770 [No Abstract] [Full Text] [Related]
11. [ON THE DETERMINATION OF THE NEUROVIRULENCE OF LIVE POLIOVIRUS VACCINES. II. PATHOMORPHOLOGY OF APE POLIOMYELITIS CAUSED BY ATTENUATED POLIOVIRUSES AFTER INTRALUMBAR INJECTION WITH SPECIAL REFERENCE TO DIFFERENCES BETWEEN THE VIRUS TYPES]. UNTERHARNSCHEIDT F; BONIN O Arch Psychiatr Nervenkr; 1965 Mar; 206():454-73. PubMed ID: 14271779 [No Abstract] [Full Text] [Related]
12. THERMORESISTANCE TESTING FOR IDENTIFICATION OF LSC 2AB VIRUS PROGENY. JANDA Z; VONKA V Arch Gesamte Virusforsch; 1964; 14():227-37. PubMed ID: 14141582 [No Abstract] [Full Text] [Related]
13. [OBSERVATIONS ON THE CULTURE OF POLIOVIRUS STRAINS FROM THE BLOOD AFTER VACCINATION WITH SABIN VACCINE L SC 2 AB]. GRUETZNER L Zentralbl Bakteriol Orig; 1963 Dec; 191():90-1. PubMed ID: 14119947 [No Abstract] [Full Text] [Related]
14. [ON THE VIABILITY AND RESISTANCE OF VACCINAL STRAINS OF POLIOVIRUSES IN THE EXTERNAL ENVIRONMENT]. BYCHKOVSKAIA OV; BABINA NS; IVANOVA OD; KISELEVA LF Gig Sanit; 1964 Aug; 29():45-9. PubMed ID: 14249261 [No Abstract] [Full Text] [Related]
15. THE STABILIZING EFFECT OF L-CYSTINE ON THE THERMAL INACTIVATION OF POLIOVIRUS. I. DIFFERENTIATION OF THE STRAINS OF POLIOVIRUS BY HEATING WITH L-CYSTINE. IKEGAMI N; YOSHIKAWA E; TAGAYA I Jpn J Med Sci Biol; 1963 Dec; 16():325-42. PubMed ID: 14130752 [No Abstract] [Full Text] [Related]
16. CHARACTERISTICS OF ATTENUATED TYPE 3 POLIOVIRUS OBTAINED BY ALTERNATE PASSAGES IN CHICK CELL CULTURES AND MONKEY KIDNEY CELL CULTURES. TAKAHASHI M; HAMADA T; OKABE S Biken J; 1963 Oct; 6():219-22. PubMed ID: 14147715 [No Abstract] [Full Text] [Related]
17. A STUDY OF SABIN TYPE 1 ORAL VACCINE VIRUS DURING FIVE HUMAN PASSAGES. PAVILANIS V; LUSSIER G; FOLEY AR; CHARBONNEAU JH; DIFRANCO E; DUBREUIL R Rev Can Biol; 1964 Sep; 23():265-76. PubMed ID: 14237159 [No Abstract] [Full Text] [Related]
18. ANTIGENIC VARIATIONS AMONG TYPE III POLIOMYELITIS VIRUSES. DEIBEL R; MACDONALD D N Y State J Med; 1964 Aug; 64():2058-65. PubMed ID: 14180893 [No Abstract] [Full Text] [Related]
19. [WHAT DOES THE TESTING OF VIRAL VACCINES DO FOR THE HARMLESSNESS OF VACCINES IN THEIR PRACTICAL USE?]. BONIN O; GUENTHER O Med Welt; 1964 Apr; 15():822-31. PubMed ID: 14194499 [No Abstract] [Full Text] [Related]
20. DEXTRAN SULFATE PLAQUE VARIANTS OF ATTENUATED TYPE 1 POLIOVIRUS. RELATIONSHIP TO IN VITRO AND IN VIVO MARKERS. TAKEMOTO KK; KIRSCHSTEIN RL J Immunol; 1964 Feb; 92():329-33. PubMed ID: 14160455 [No Abstract] [Full Text] [Related] [Next] [New Search]